SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-037049
Filing Date
2023-10-12
Accepted
2023-10-12 16:26:05
Documents
13
Period of Report
2023-10-12
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 99159
2 ex10-1.htm EX-10.1 13519
  Complete submission text file 0001493152-23-037049.txt   290370

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE vblt-20231012.xsd EX-101.SCH 3006
4 XBRL LABEL FILE vblt-20231012_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE vblt-20231012_pre.xml EX-101.PRE 22353
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3092
Mailing Address HASATAT 8 ST. MODI'IN, L3 7178106
Business Address HASATAT 8 ST. MODI'IN, L3 7178106 972-3-6346450
Vascular Biogenics Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36581 | Film No.: 231322993
SIC: 2834 Pharmaceutical Preparations